​

Funding Round

Series B - Cadent Therapeutics

Series B - Cadent Therapeutics

Investment Firm

Overview

Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.

Announced Date

Nov 15, 2018

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Atlas Venture

Atlas Venture

Atlas Venture is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorNovartis Institutes for Biomedical Research
Participant InvestorAtlas Venture
Participant InvestorQiming Venture Partners

Round Details and Background

Cadent Therapeutics raised $40000000 on 2018-11-15 in Series B

Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 29, 2020
Series B - Cadent Therapeutics
6-15.0M
Jun 28, 2010
Seed Round - Cadent Therapeutics
1-250.0K
Jun 21, 2013
Series A - Cadent Therapeutics
2-6.0M
Feb 16, 2012
Series A - Cadent Therapeutics
2-5.4M

Recent Activity

There is no recent news or activity for this profile.